Amgen Inc

Healthcare · Drug Manufacturers - General

410.20$ +4.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Amgen Inc (AMGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 95,639 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AMGN
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	90,534	97,154	92,980	90,907	90,883	91,839	89,367	87,897	90,141	90,586	92,504	95,639
Current Assets	48,477	30,332	28,029	27,206	26,766	29,030	26,929	26,734	27,885	29,057	31,475	34,961
Cash	34,741	10,944	9,708	9,301	9,011	11,973	8,810	8,028	9,445	9,129	12,038	13,989
Cash & Short-Term Investments	34,741	10,944	9,708	9,301	9,011	11,973	8,810	8,028	9,445	9,129	12,038	13,989
Receivables	6,145	7,942	6,776	6,934	7,317	7,501	8,132	8,701	8,490	9,570	9,138	10,227
Inventory	5,026	9,518	8,724	7,995	7,362	6,998	6,729	6,583	6,346	6,225	6,186	6,220
Goodwill	15,509	18,629	18,570	18,616	18,658	18,637	18,645	18,674	18,676	18,680	18,674	18,668
Intangible Assets	13,150	32,641	31,372	30,172	28,920	27,699	25,724	24,614	23,139	22,276	21,379	20,487
Total Liabilities	82,878	90,922	87,958	84,982	83,356	85,962	83,160	80,469	80,522	81,928	83,314	83,951
Current Liabilities	16,954	18,392	19,714	21,517	20,312	23,099	23,008	20,476	21,791	25,489	24,955	25,502
Short-Term Debt	1,428	1,443	3,959	5,528	3,544	3,550	3,368	2,444	2,153	4,599	5,437	5,445
Accounts Payable	1,358	1,590	1,628	2,267	2,147	1,908	2,406	3,010	2,838	2,367	2,935	20,057
Long-Term Debt	59,040	63,170	60,061	57,117	56,854	56,549	54,013	53,760	52,434	50,005	51,886	51,859
Shareholders' Equity	7,656	6,232	5,022	5,925	7,527	5,877	6,207	7,428	9,619	8,658	9,190	11,688
Retained Earnings	-24,971	-26,549	-27,870	-27,124	-25,530	-27,590	-27,140	-25,708	-23,800	-25,107	-24,650	-22,275
Shares Outstanding	538	540	536	541	542	542	541	541	542	543	544	544

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings